- 疾病机制
- 王建枝 吴立玲 陈琪
- 193字
- 2020-08-28 08:40:23
参考文献
[1]Biddinger SB,Kahn CR.From mice to men:insights into the insulin resistance syndromes.Annu Rev Physiol,2006,68:123-158.
[2]Li J,Chi Y,Wang C,et al.PANcreatic DERived factor promotes lipogeneis in the liver:the role of FOXO1 signaling.Hepatology,2011,53(6):1906-1916.
[3]Qatanani M,Lazar MA.Mechanisms of obesity-associated insulin resistance:many choices on the menu.Genes Dev,2007,21(12):1443-1455.
[4]Fabricatore AN,Wadden TA.Obesity.Annu Rev Clin Psychol,2006,2:357-377.
[5]Taniguchi CM,Emanuelli B,Kahn CR.Critical nodes in signalling pathways:insights into insulin action.Nat Rev Mol Cell Biol,2006,7(2):85-96.
[6]Henquin JC.Regulation of insulin secretion:a matter of phase control and amplitude modulation.Diabetologia,2009,52(5):739-751.
[7]Ahima RS,Osei SY.Adipokines in obesity.Front Horm Res,2008,36:182-197.
[8]Herder C,Roden M.Genetics of type 2 diabetes:pathophysiologic and clinical relevance.Eur J Clin Invest,2011,41(6):679-692.